Your session is about to expire
← Back to Search
Text Message Reminders for Health Maintenance
N/A
Waitlist Available
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week after getting the reminder
Awards & highlights
Study Summary
This trial aims to see if text message reminders can help patients follow their preventive care plans.
Who is the study for?
This trial is for adult patients of UCLA Health's DOM Primary Care with overdue health maintenance measures, active MyChart status, and can receive SMS messages. They must have a July birthday and not opened the My Action Plan letter within 7 days. Excluded are those under 18, deceased or in hospice care, or who opt out of electronic communication.Check my eligibility
What is being tested?
The study tests if text message reminders about preventive care can increase patient engagement with primary care services at UCLA Health. It compares different types of persuasive texts: anecdotes with and without links to more information, and persuasion based on research findings.See study design
What are the potential side effects?
Since this trial involves non-medical interventions (text message reminders), there are no direct physical side effects associated with traditional clinical trials that test drugs or medical procedures.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 week after getting the reminder
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week after getting the reminder
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Opening link within SMS Text message
Secondary outcome measures
Completion rate of one screening/test
Direct scheduling appointment rate
MyChart letter opened
+1 moreTrial Design
4Treatment groups
Experimental Treatment
Group I: Research-based ReminderExperimental Treatment2 Interventions
Eligible, randomized participants will receive a text message reminding them to close their outstanding health gap. This message will mention that research has shown promptly closing health gaps saves lives. The message will contain a link to an official website that supports the statement.
Group II: Control ReminderExperimental Treatment1 Intervention
Eligible, randomized participants will receive a generic text message reminding them to close their outstanding health gap.
Group III: Anecdote-based Reminder without linkExperimental Treatment2 Interventions
Eligible, randomized participants will receive a text message reminding them to close their outstanding health gap. This message will contain an anecdote of a patient whose cancer was caught early through similar, recommended preventive screenings. The message won't contain a link to the story, but it will briefly describe the story.
Group IV: Anecdote-based ReminderExperimental Treatment2 Interventions
Eligible, randomized participants will receive a text message reminding them to close their outstanding health gap. This message will contain an anecdote of a patient whose cancer was caught early through similar, recommended preventive screenings. The message prompts patients to click on a link to read the story about the patient.
Find a Location
Who is running the clinical trial?
University of California, Los AngelesLead Sponsor
1,528 Previous Clinical Trials
10,266,851 Total Patients Enrolled
UCLA Health Department of MedicineUNKNOWN
3 Previous Clinical Trials
72,046 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have chosen not to receive electronic communications.I am under 18 years old.My birthday is in July.
Research Study Groups:
This trial has the following groups:- Group 1: Anecdote-based Reminder without link
- Group 2: Control Reminder
- Group 3: Anecdote-based Reminder
- Group 4: Research-based Reminder
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any available vacancies in this trial for participants?
"As per the details available on clinicaltrials.gov, this trial has already concluded its patient recruitment process. The study was published July 27th 2023 and last revised on July 30th 2023; however, 715 other trials are still actively enrolling individuals at present."
Answered by AI
Share this study with friends
Copy Link
Messenger